mTORC1 inhibitors improve healthspan and lifespan.

 

mTOR signaling is deregulated in common diseases, like cancer and epilepsy, and mTORC1 is a well-validated modulator of aging in multiple model organisms. There is significant excitement around using to treat cancer and neurological disease as well

David Sabatini